Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.22
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2016, vol. 53, nr 2, April-June, p. 273–277

doi: 10.17219/dmp/61785

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

The Role of Stabilized Stannous Fluoride and Sodium Hexametaphosphate Contained in Toothpastes in Preventing Tartar Deposition and Tooth Discoloration

Rola stabilizowanego fluorku cyny i sześciometafosforanu sodu zawartych w pastach do zębów w zapobieganiu tworzenia się kamienia nazębnego i przebarwień zębów

Anna Surdacka1,A,B,C,D,E,F

1 Department of Conservative Dentistry and Periodontology, Poznan University of Medical Sciences, Poznań, Poland


On the basis of the literature, the paper proves that toothpastes containing stabilized stannous fluoride – sodium hexametaphosphate (SHMP) effectively and safely reduce tartar formation. Inhibition of tartar, and thus the reservoir of the live bacteria, contribute to the reduction of periodontal inflammation. In vitro studies have shown that pyrophosphate inhibits the growth and mineralization of dental plaque by a chelate effect of the minerals. Showing a very strong affinity to the surface of hydroxyapatite, strongly bound to the tooth surface and tartar, and coating the new embryos, it inhibits the growth of mineral crystals. Tartar formation can be prevented through regular, proper tooth brushing using not only brushes but also dental floss and dentifrices which contain chemicals preventing calculus formation. The toothpastes remove external stains and their effectiveness is comparable to the whitening ones. They also have bleaching properties which are important because of the aesthetic aspect. SHMP was shown to be highly chemically active agent for stain prevention and reduction of the pellicle conditioning film thicknesses.

Key words

toothpastes, stannous fluoride, sodium hexametaphosphate, dental calculus

Słowa kluczowe

pasty do zębów, fluorek cyny, sześciometafosforan sodu, kamień nazębny

References (32)

  1. White D.J.: Dental calculus: recent insights into occurrence, formation, prevention, removal and oral health effects of supragingival and subgingival deposits. Eur. J. Oral Sci. 1997, 105, 508–522.
  2. Anderud A., Loe H., Boysen H.: The natural history and clinical course of calculus formation in man. J. Clin. Periodontol. 1991, 18, 160–170.
  3. Friskopp J., Isacsson G.: A quantitative microradiographic study of mineral content of supragingival and subgingival dental calculus. Scand. J. Dent. Res. 1984, 92, 25–32.
  4. Kodaka T., Derbari K., Ymada M.: Heterogeneity of crystals attached to the human enamel and cementum surfaces after calculus removal in vitro. Scanning Microscopy, 1991, 5, 713–721.
  5. Tsuda H., Arends J.: Raman spectra of human dental calculus. J. Dent. Res. 1993, 72, 1609–1613.
  6. Okumura H., Nakagaki H., Kato K., Ito F., Weatherall J.A., Robinson C.: Distribution of fluoride in human dental calculus. Caries Res. 1993, 27, 271– 276.
  7. Tan B., Gillam D.G., Mordan N.J., Galgut P.N.: A preliminary investigation into the ultrastructure of dental calculus and associated bacteria. J. Clin. Periodontol. 2004, 31, 364–369.
  8. Friskopp J., Hammarstrom L.: Ultrastructure of nondecalcified supra and subgingival calculus. J. Periodontol. 1980, 51, 553–562.
  9. Friskopp J.: Ultrastructure of nondecalcified supragingival and subgingival calculus. J. Periodontol.1983, 54, 542–550.
  10. Tan B.T.K., Mordan N.J., Pratten J., Galgut P.N.: Study of bacterial viability within human supragingival dental calculus. J. Periodontol. 2004, 75, 23–29.
  11. Mandel I.D., Gaffar A.: Calculus revisited. A review. J. Clin. Periodontol. 1986, 13, 249–257.
  12. Sidaway D.A.: A microbiological study of dental calculus. IV. An electron microscopic study of in vitro calcified microorganisms. J. Periodontol. Res. 1980, 15, 240–254.
  13. Lobene R.R.: A clinical study of the anticalculus effect of a dentifrice containing soluble pyrophosphate and sodium fluoride. Clin. Prev. Dent. 1986, 8, 5–7.
  14. Gaengler P., Kurbad A., Weinert W.: Evaluation of anti-calculus efficacy. An SEM method of evaluating the effectiveness of pyrophosphate dentifrice on calculus formation. J. Clin. Periodont. 1993, 20, 144–146.
  15. Rykke M., Rolla G.: Desorption of acquired enamel pellicle in vivo by pyrophosphate. Scand. Dent. J. Res. 1990, 98, 211–214.
  16. Rykke M., Rolla G., Sonju T.: Effect of pyrophosphate on protein adsorption to hydroxyapatite in vitro and in on pellicle formation in vivo. Scand. J. Dent. Res. 1988, 96, 517–522.
  17. White D.J., Gerlach R.W.: Anticalculus effects of a novel, dual-phase polypyrophosphate dentifrice: chemical basis, mechanism, and clinical response. J. Contemp. Dent. Pract. 2000, 1, 4, 1–12.
  18. White D.J., Cox E.R., Suszczynsky-Meister E.M., Baig A.A.: In vitro studies of the anticalculus efficacy of a sodium hexametaphosphate whitening dentifrice. J. Clin. Dent. 2002, 13, 33–37.
  19. Liu H., Segrato V., Baker R., Vastola K., Ramsey L., Gerlach R.: Anticalculus efficacy and safety of a novel whitening dentifrice containing sodium hexametaphosphate: a controlled six-month clinical trial. J. Clin. Dent. 2002 13, 25–28.
  20. Schiff T., Saletta L., Baker R.A., He T., Winston J.L.: Anticalculus efficacy and safety of stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Compend. Contin. Educ. Dent. 2005, 26, 9, Suppl. 1, 29–34.
  21. Volpe A.R., Manhold J.H., Hazen S.P.: In vivo calculus assessment. I. A method and its examiner reproducibility. J. Periodontol. 1965, 36, 32–38.
  22. Lobene R.R.: Effect of dentifrices on tooth stain with controlled brushing. J. Am. Dent. Assoc. 1968, 77, 849–855.
  23. Winston J.L., Fiedler S.K., Schiff T., Baker R.A.: An anticalculus dentifrice with sodium hexametaphosphate and stannous fluoride: a six-month study of efficacy. J. Contemp. Dent. Pract. 2007, 8, 5, 1–9.
  24. He T., Winston L., Fiedler S., Baker R.: Superior anticalculus efficacy of an experimental SnF2 dentifrice. J. Dent. Res. (AADR/IADR). 2008, 87, Abstr. 1084.
  25. Milleman J.L., Putt M.S., Wintergerst A., Barker M.L., He T.: Three month clinical trial on the anti-calculus effects of two dentifrices. J. Dent. Res. 2011, 90, Spec Iss A, Abstr. 1316.
  26. Baig A.A., Kozak K.M., Cox E.R., Zoladz J.R., Mahony L., White D.J.: Laboratory studies on the chemical whitening effects of a sodium hexametaphosphate dentifrice. J. Clin. Dent. 2002, 13, 19–24.
  27. Busscher H.J., White D.J., van der Mei H.C., Baig A.S., Kozak K.M.: Hexametaphosphate effects on tooth surface conditioning film chemistry – in vitro and in vivo studies J. Clin. Dent. 2002, 13, 38–43.
  28. He T., Baker R., Bartizek R.D., Biesbrock A.R., Chaves E., Terezhalmy G.: Extrinsic stain removal efficacy of stannous fluoride dentifrice with sodium hexametaphosphate. J. Clin. Dent. 2007,18, 7–11.
  29. Terezhalmy G., Chaves E., Bsoul S.: Clinical evaluation on the stain removal efficacy of a novel stannous fluoride and sodium hexametaphosphate dentifrice. Am. J. Dent. 2007, 20, 53–58.
  30. Gerlach R.W., He T., Biesbrock A.R.: 0.454% stannous fluoride dentifrice and tooth staining: composite evidence. J. Dent. Res. 2007, 86, Spec Iss. Abstr. 691.
  31. Amini A., Amini P., Anastasia M.K., Sagel P.A., Gerlach R.W.: SnF2/H2O2 sequential hygiene: correlations between therapeutic and esthetic responses. IADR General Session, March 2015, Boston, Abstr. 1643.
  32. Amini A., Anastasia M.K., Sagel P.A., Gerlach R.W.: 1-week effects of paste/gel sequence on gingivitis and stain. IADR General Session, 11–14 March 2015, Boston, Abstr. 1642.